HCM
HUTCHMED DRC
14.20$
+0.0%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 42.6% | 39.0% | 48.9% | 72.3% | 69.6% | 68.2% | 73.3% | 88.3% | 81.6% | 85.7% | 83.7% | 89.4% | |
| 18.5% | 13.9% | 23.2% | 14.3% | 16.2% | 26.0% | 32.5% | 27.5% | 30.4% | 22.2% | 12.1% | 4.1% | |
| 24.2% | 13.9% | 30.3% | 59.9% | 56.6% | 46.7% | 60.1% | 73.7% | 61.3% | 69.3% | 65.6% | 78.0% | |
| 15.4% | 19.9% | 14.2% | 9.6% | 8.2% | 16.6% | 6.6% | 10.8% | 12.3% | 11.8% | 13.2% | 8.4% | |
| 2.1% | 4.2% | 3.7% | 2.0% | 2.3% | 3.5% | 2.7% | 2.6% | 5.5% | 3.9% | 4.0% | 2.3% | |
| 3.5% | 4.3% | 2.9% | 2.4% | 3.1% | 5.7% | 4.4% | 3.9% | 8.2% | – | – | – | |
| 0.9% | 1.5% | 0.9% | 0.6% | 0.6% | 0.7% | 0.5% | 0.2% | 0.3% | 0.2% | 0.2% | 0.2% | |
| 0.3% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.5% | |
| 53.5% | 55.5% | 40.4% | 18.9% | 22.5% | 32.7% | 28.3% | 24.3% | 38.1% | 41.9% | 39.4% | 28.6% | |
| 35.7% | 35.3% | 27.8% | 17.5% | 16.1% | 24.3% | 21.9% | 22.7% | 34.4% | 31.5% | 29.6% | 18.0% | |
| 16.6% | 11.9% | 6.5% | 5.4% | 0.1% | 0.8% | 0.8% | 2.3% | 0.4% | 2.7% | 2.1% | 1.6% | |
| 9.7% | 10.5% | 10.4% | 4.1% | 4.8% | 5.2% | 4.4% | 3.0% | 6.9% | 2.8% | 3.3% | 2.6% | |
| 14.3% | 11.7% | 7.8% | 0.0% | 5.0% | 5.8% | 3.7% | 0.0% | 1.8% | 3.8% | 4.7% | 3.9% | |
| 18.6% | 36.3% | 53.8% | 77.2% | 73.1% | 61.9% | 66.9% | 71.9% | 59.3% | 57.1% | 59.6% | 70.6% | |
| -47.5% | -40.1% | -23.5% | -17.9% | -34.4% | -62.3% | -57.4% | -44.5% | -94.4% | -68.0% | -65.4% | -21.6% | |
| 50.2% | 47.6% | 35.0% | 20.6% | 25.0% | 28.6% | 3.9% | 11.5% | 16.5% | 13.6% | 13.7% | 10.0% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.